Albia, Ann-hyacent Mae .
HRN: 24-26-11 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/17/2023
AMPICILLIN 1GM (VIAL)
12/17/2023
12/19/2023
IV
2 G
Q6
Thickly MSAF PROM
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes